XML 63 R46.htm IDEA: XBRL DOCUMENT v3.22.1
Long-Term Investments (Details) - Schedule of extent the investee relies
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Braingenesis Biotechnology Co., Ltd. [Member]    
Long-Term Investments (Details) - Schedule of extent the investee relies [Line Items]    
Relationship with the Company and its subsidiaries, description No specific business relationship No specific business relationship
Genepharm Biotech Corporation [Member]    
Long-Term Investments (Details) - Schedule of extent the investee relies [Line Items]    
Relationship with the Company and its subsidiaries, description No specific business relationship No specific business relationship
BioHopeKing Corporation [Member]    
Long-Term Investments (Details) - Schedule of extent the investee relies [Line Items]    
Relationship with the Company and its subsidiaries, description Collaborating with the Company to develop and commercialize drugs Collaborating with the Company to develop and commercialize drugs
BioFirst Corporation [Member]    
Long-Term Investments (Details) - Schedule of extent the investee relies [Line Items]    
Relationship with the Company and its subsidiaries, description Collaborating with the Company to develop and commercialize drugs Loaned from the investee and provides research and development support service
Rgene Corporation [Member]    
Long-Term Investments (Details) - Schedule of extent the investee relies [Line Items]    
Relationship with the Company and its subsidiaries, description Collaborating with the Company to develop and commercialize drugs Collaborating with the Company to develop and commercialize drugs